Exogenous administration of adiponectin or overexpression in transgenic mice results in improved insulin sensitivity whereas adiponectin deficient mice develop HFD-induced inflammation and insulin resistance (Maeda et al., 2002; Kim et al., 2007b). The gene discussed is INS; the disease is Insulin resistance.